① Thirty-nine A-share listed companies, including Jinshan Office, announced plans to repurchase or increase their holdings up to 100 million yuan or more (attached table). Among them, Ed Biotech, Chinese Media, and Bose Co., Ltd. all indicated that the repurchase was used for cancellation; ② Artes ranked first. Qu Xiaohua, the company's actual controller and chairman, proposed to repurchase shares at 500 million yuan to 1 billion yuan.
Finance Association, Feb. 7 (Editor Ruo Yu) According to financial news agency's incomplete statistics, as of press release, a total of 39 listed companies have disclosed plan announcements with a maximum repurchase or increase in holdings of 100 million yuan or more. Among them, Artes, Hangjin Technology, Happy Home, Yuyuan Co., Ltd., Junyao Health, Aide Biotech, Dafeng Industrial, Donggang, Lan Sheng, Huanxu Electronics, Changgao Electronics, Changgao Electric, Novo Zhiyuan, Pan-Micro Networks, Hejing Biotech, Yongguan New Materials, Oriental Biotech, Jingweirun, Jingweirun Hongrun Construction, Simei Media, Chinese Media, Huayuan Holdings, Bose Co., Ltd., Suzhou Keda, Pu Nai Co., Ltd., Zheng Zhong Design, Ashi Chuangneng, Fuda Co., Ltd., Jiaxin Silk, Jinshan Office, Shanggong Shenbei, Shentong Technology, Xintian Pharmaceutical, Liancheng Precision, Huamao Co., Ltd., Taifu Pump, Yuanjie Technology, and Yidong Electronics have a total of 37 companies.
At the same time, only 2 companies have disclosed plans to increase their holdings. Ni Zhanggen, the controlling shareholder of Dream Lily, plans to increase its holdings by 80 million yuan to 160 million yuan. There is no price range for this increase; Fugang Electronics, a concerted actor with shareholders holding 5% or more of Co-Creation Data, plans to increase their holdings by 50 million yuan to 100 million yuan. The current increase plan does not set a price range.
Among the many repurchase plan announcements, Artes ranked first in the maximum amount of the proposed repurchase amount. According to the Artes announcement, Qu Xiaohua, the company's actual controller and chairman, proposed to buy back the shares for 500 million yuan to 1 billion yuan. According to information, Artes is in the first tier of global PV module suppliers and is in the top five module product shipments in the industry. Zhang Wenchen of Huajin Securities and others reported on January 29 that Artes is rapidly advancing the construction of integrated photovoltaic production capacity and continuing to expand the energy storage market. The performance will maintain rapid growth. The company's net profit in 2023 is expected to be 3,654 billion yuan, an increase of 69.4% over the previous year. However, in the secondary market, the biggest cumulative decline in Artes's stock price since January 19 was 25.08%. Over a long period of time, the company's stock price peaked in June 2023 and fell back. The biggest cumulative decline so far was 46.85%.
Jinshan Office plans to repurchase shares for 50 million yuan to 100 million yuan, with a repurchase price of no more than RMB 380 per share. In the secondary market, the company's stock price also began a deep correction after reaching a record high in June 2023, with the biggest cumulative decline of 62.52% so far.
Furthermore, Ed Biotech, Chinese Media, and Bose Co., Ltd. have all indicated that the shares are to be repurchased for cancellation, etc. Specifically, Ed Biotech plans to repurchase the company's shares for 100 million yuan to 200 million yuan, which will be used to cancel and reduce the company's registered capital; both Chinese Media and Bose Co., Ltd. plan to repurchase shares at 50 million yuan to 100 million yuan, all of which will be used to cancel and reduce the registered capital. Among them, Bose shares have recently declined the most. The company's stock price has fallen by 40.66% since January 18, and a cumulative correction of 67.65% since August 2021.
According to incomplete statistics from the Financial Federation, as of press release, a number of A-share listed companies, such as I miss you, Dalian Heavy Industries, Arcsoft Technology, and Bangbiotech, have disclosed the progress or completion of the repurchase, including announcements from various listed companies such as Juguang Technology and Asia Pacific Pharmaceutical disclosing the progress or completion of the increase in their holdings.